Clinical Trials Directory

Trials / Completed

CompletedNCT02155023

Feasibility Study to Determine the Optimal Calibration Method for Glucose Sensors

An Open, Single-centre, Non-controlled Feasibility Study to Determine the Optimal Calibration Method for Glucose Sensors Used for Continuous Glucose Monitoring in Patients With Type 1 Diabetes

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
8 (actual)
Sponsor
Medical University of Graz · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Accepted

Summary

Two new glucose sensors (IR-Glucose Reader (Joanneum Research, Austria), IR-CGM (IMM, Germany)) will be investigated to determine the optimal calibration method in patients with type 1 diabetes

Detailed description

The subjects (Type 1 diabetes) will stay at the Clinical Research Centre for the whole period of the investigation (12 hours). Continuous blood glucose monitoring will be performed using the IR-Glucose Reader system and/or the IR-CGM system based on microdialysis. In parallel blood glucose measurements will be performed every 15 min as reference. The measurements of the sensors will be calibrated with different schemes and the difference between the calibrated glucose readings and the reference blood glucose values will be determined.

Conditions

Interventions

TypeNameDescription
DRUGInsulin dosing
DEVICEGlucose sensors IR-Glucose Reader (Joanneum Research, Austria), IR-CGM (IMM, Germany)

Timeline

Start date
2014-01-01
Primary completion
2015-01-01
Completion
2015-01-01
First posted
2014-06-04
Last updated
2015-03-26

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT02155023. Inclusion in this directory is not an endorsement.